Progression of aggressive non-Hodgkin's lymphoma (NHL) slowed significantly after autologous stem cell transplantation, although overall survival did not improve.Point out that the lack of survival benefit, long duration of enrollment and follow-up, and other factors will likely preclude the trial results from having a major impact on clinical practice.